May 2006
Volume 47, Issue 13
Free
ARVO Annual Meeting Abstract  |   May 2006
Passive Immunization of Rabbits With Pneumolysin Antiserum to Treat Streptococcus Pneumoniae Keratitis
Author Affiliations & Notes
  • M.E. Marquart
    Microbiology, University of Mississippi Medical Center, Jackson, MS
  • K.S. Monds
    Microbiology, Louisiana State University Health Sciences Center, New Orleans, LA
  • A.R. Caballero
    Microbiology, University of Mississippi Medical Center, Jackson, MS
  • L.S. McDaniel
    Microbiology, University of Mississippi Medical Center, Jackson, MS
  • R.J. O'Callaghan
    Microbiology, University of Mississippi Medical Center, Jackson, MS
  • Footnotes
    Commercial Relationships  M.E. Marquart, None; K.S. Monds, None; A.R. Caballero, None; L.S. McDaniel, None; R.J. O'Callaghan, None.
  • Footnotes
    Support  NIH Grant EY10974, LSU Health Sciences Center Foundation Grant
Investigative Ophthalmology & Visual Science May 2006, Vol.47, 1078. doi:https://doi.org/
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      M.E. Marquart, K.S. Monds, A.R. Caballero, L.S. McDaniel, R.J. O'Callaghan; Passive Immunization of Rabbits With Pneumolysin Antiserum to Treat Streptococcus Pneumoniae Keratitis . Invest. Ophthalmol. Vis. Sci. 2006;47(13):1078. doi: https://doi.org/.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: : Test polyclonal antiserum, raised against the toxin pneumolysin, for the passive treatment of pneumococcal keratitis.

Methods: : Rabbit anti–pneumolysin polyclonal antiserum was produced by immunizing each of 3 New Zealand white rabbits subcutaneously with a 1:1 mixture of complete Freund’s adjuvant and 0.1 mg recombinant pneumolysin, and then boosting with a 1:1 mixture of incomplete Freund’s adjuvant and 0.05 mg recombinant pneumolysin 3 weeks later. Control serum was generated by injecting rabbits with a 1:1 mixture of Freund’s and PBS. The serum from the rabbit producing the highest ELISA titer of pneumolysin antiserum was chosen for passive immunization. Six new rabbits were injected intrastromally with 100,000 colony–forming units (CFU) of S. pneumoniae strain WU2. Three of these rabbits were given 1 ml of pneumolysin antiserum intravenously immediately following infection, whereas the remaining 3 were given 1 ml of control serum. Slit lamp examinations (SLE) of eyes were done at 24, 36, and 48 hours post–infection. Rabbits were sacrificed following the last SLE and corneal CFU were determined by dilution plating of corneal homogenates.

Results: : The anti–pneumolysin serum used for passive immunization produced an ELISA titer of approximately 50,000, and the control serum had a background titer of 200. SLE scores of passively immunized rabbits (n = 6 corneas) were significantly lower than the control rabbits (n = 5 corneas) at 36 hours post–infection (6.833 ± 0.528 vs. 10.350 ± 0.490, respectively; P = 0.001) and 48 hours post–infection (7.417 ± 1.233 vs. 13.050 ± 1.220, respectively; P = 0.011). The most striking difference observed was the amount of infiltrate in the corneal stroma. Log CFU at 48 hours post–infection were not significantly different between passively immunized (2.617 ± 1.136) and control (2.124 ± 0.798) rabbit corneas (P = 0.742).

Conclusions: : Passive immunization with pneumolysin antiserum significantly reduced the symptoms of S. pneumoniae keratitis.

Keywords: bacterial disease • cornea: basic science • keratitis 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×